Epigenetic strategies to boost CAR T cell therapy

被引:43
作者
Akbari, Behnia [1 ]
Ghahri-Saremi, Navid [1 ]
Soltantoyeh, Tahereh [1 ]
Hadjati, Jamshid [1 ]
Ghassemi, Saba [2 ]
Mirzaei, Hamid Reza [1 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Dept Med Immunol, Tehran 1417613151, Iran
[2] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
CHIMERIC ANTIGEN RECEPTOR; HISTONE DEACETYLASE INHIBITORS; NOVO DNA METHYLATION; GENE-EXPRESSION; INTRACHROMOSOMAL INTERACTIONS; DIFFERENTIAL EXPRESSION; REGULATES EFFECTOR; VIRUS-INFECTION; UP-REGULATION; CANCER CELLS;
D O I
10.1016/j.ymthe.2021.08.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chimeric antigen receptor (CAR) T cell therapy has led to a paradigm shift in cancer immunotherapy, but still several obstacles limit CAR T cell efficacy in cancers. Advances in high throughput technologies revealed new insights into the role that epigenetic reprogramming plays in T cells. Mechanistic studies as well as comprehensive epigenome maps revealed an important role for epigenetic remodeling in T cell differentiation. These modifications shape the overall immune response through alterations in T cell phenotype and function. Here, we outline how epigenetic modifications in CAR T cells can overcome barriers limiting CAR T cell effectiveness, particularly in immunosuppressive tumor microenvironments. We also offer our perspective on how selected epigenetic modifications can boost CAR T cells to ultimately improve the efficacy of CAR T cell therapy.
引用
收藏
页码:2640 / 2659
页数:20
相关论文
共 224 条
[51]   Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity [J].
He, Shan ;
Liu, Yongnian ;
Meng, Lijun ;
Sun, Hongxing ;
Wang, Ying ;
Ji, Yun ;
Purushe, Janaki ;
Chen, Pan ;
Li, Changhong ;
Madzo, Jozef ;
Issa, Jean-Pierre ;
Soboloff, Jonathan ;
Reshef, Ran ;
Moore, Bethany ;
Gattinoni, Luca ;
Zhang, Yi .
NATURE COMMUNICATIONS, 2017, 8
[52]   CTCF regulates cell cycle progression of αβ T cells in the thymus [J].
Heath, Helen ;
de Almeida, Claudia Ribeiro ;
Sleutels, Frank ;
Dingjan, Gemma ;
van de Nobelen, Suzanne ;
Jonkers, Iris ;
Ling, Kam-Wing ;
Gribnau, Joost ;
Renkawitz, Rainer ;
Grosveld, Frank ;
Hendriks, Rudi W. ;
Galjart, Niels .
EMBO JOURNAL, 2008, 27 (21) :2839-2850
[53]   Loss of T cell receptor-induced Bmi-1 in the KLRG1+ senescent CD8+ T lymphocyte [J].
Heffner, Maike ;
Fearon, Douglas T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (33) :13414-13419
[54]   Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance [J].
Hennequart, Marc ;
Pilotte, Luc ;
Cane, Stefania ;
Hoffmann, Delia ;
Stroobant, Vincent ;
De Plaen, Etienne ;
van den Eynde, Benio T. J. .
CANCER IMMUNOLOGY RESEARCH, 2017, 5 (08) :695-709
[55]   Epigenetic control of CD8+ T cell differentiation [J].
Henning, Amanda N. ;
Roychoudhuri, Rahul ;
Restifo, Nicholas P. .
NATURE REVIEWS IMMUNOLOGY, 2018, 18 (05) :340-356
[56]   Silencing stemness in T cell differentiation [J].
Henning, Amanda N. ;
Klebanoff, Christopher A. ;
Restifo, Nicholas P. .
SCIENCE, 2018, 359 (6372) :163-164
[57]   Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity [J].
Hermans, Dalton ;
Gautam, Sanjivan ;
Garcia-Canaveras, Juan C. ;
Gromer, Daniel ;
Mitra, Suman ;
Spolski, Rosanne ;
Li, Peng ;
Christensen, Stephen ;
Nguyen, Rosa ;
Lin, Jian-Xin ;
Oh, Jangsuk ;
Du, Ning ;
Veenbergen, Sharon ;
Fioravanti, Jessica ;
Ebina-Shibuya, Risa ;
Bleck, Christopher ;
Neckers, Leonard M. ;
Rabinowitz, Joshua D. ;
Gattinoni, Luca ;
Leonard, Warren J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (11) :6047-6055
[58]   Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses [J].
Ho, Ping-Chih ;
Bihuniak, Jessica Dauz ;
Macintyre, Andrew N. ;
Staron, Matthew ;
Liu, Xiaojing ;
Amezquita, Robert ;
Tsui, Yao-Chen ;
Cui, Guoliang ;
Micevic, Goran ;
Perales, Jose C. ;
Kleinstein, Steven H. ;
Abel, E. Dale ;
Insogna, Karl L. ;
Feske, Stefan ;
Locasale, Jason W. ;
Bosenberg, Marcus W. ;
Rathmell, Jeffrey C. ;
Kaech, Susan M. .
CELL, 2015, 162 (06) :1217-1228
[59]   miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy [J].
Huang, Qian ;
Xia, Jiajia ;
Wang, Lei ;
Wang, Xu ;
Ma, Xiaodong ;
Deng, Qipan ;
Lu, Yong ;
Kumar, Munish ;
Zhou, Zhiyuan ;
Li, Ling ;
Zeng, Zhaoyang ;
Young, Ken H. ;
Yi, Qing ;
Zhang, Mingzhi ;
Li, Yong .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
[60]   Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway [J].
Insinga, A ;
Monestiroli, S ;
Ronzoni, S ;
Gelmetti, V ;
Marchesi, F ;
Viale, A ;
Altucci, L ;
Nervi, C ;
Minucci, S ;
Pelicci, PG .
NATURE MEDICINE, 2005, 11 (01) :71-76